CLINICAL TRIALS PROFILE FOR SELENOMETHIONINE SE 75
✉ Email this page to a colleague
All Clinical Trials for SELENOMETHIONINE SE 75
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00112892 ↗ | Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors | Completed | Roswell Park Cancer Institute | Phase 1 | 2004-08-01 | RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Selenium may allow higher doses of irinotecan to be given. Giving irinotecan together with selenium may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of selenium when given together with irinotecan in treating patients with advanced solid tumors. |
NCT00212186 ↗ | Selenium Supplementation of Patients With Cirrhosis | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A | 1998-10-01 | The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium. |
NCT00212186 ↗ | Selenium Supplementation of Patients With Cirrhosis | Completed | Vanderbilt University | N/A | 1998-10-01 | The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SELENOMETHIONINE SE 75
Condition Name
Clinical Trial Locations for SELENOMETHIONINE SE 75
Trials by Country
Clinical Trial Progress for SELENOMETHIONINE SE 75
Clinical Trial Phase
Clinical Trial Sponsors for SELENOMETHIONINE SE 75
Sponsor Name